For The Better

Last week, the American Medical Association (AMA) granted Tempus AI a proprietary laboratory analysis (PLA) code for its PurISTSM algorithmic test. Effective October 1, 2024, the new code will be the first common procedural terminology (CPT) code to de…

Last week, the American Medical Association (AMA) granted Tempus AI a proprietary laboratory analysis (PLA) code for its PurISTSM algorithmic test. Effective October 1, 2024, the new code will be the first common procedural terminology (CPT) code to de…

You don’t need to track stocks to make a lot of money from the markets. A solid exchange-traded fund will do.

These beaten-down blue chip stocks are struggling in 2024, but one stands out as the better buy today.

Beaten-down stocks can sometimes present an opportunity.

Shares are up for very good reasons.

Find out which crypto-related stocks are thriving in the post-halving market of 2024 and why. The answer may set you up for market-beating returns in the long run.

They don’t have the most exciting businesses, but they have a lot to offer nonetheless.

These companies have what it takes to stand the test of time in a portfolio.

Micron began getting credit for its AI upside as the memory cycle turned up.

This large-cap ETF gives investors market-beating potential while minimizing risks.

This blue chip stock has market-beating potential after a disastrous decade.

Keeping it simple can be a great strategy.

The AI wave is lifting many boats — including this legacy tech company.

UnitedHealth Group is a dividend grower with an impressive earnings track record.

Vanguard has a number of dividend ETFs. Here’s what you need to know.

A recovery plan is underway, but it isn’t a slam dunk.

Bitcoin has already made several millionaires and it still has plenty left in store.

Visa’s past stock performance proves that this is a fantastic business.

Lucid’s luxury EVs get great reviews and the stock is cheap. But there are some things you should know before you buy.